A phase I study of S-033188 for the treatment of influenza virus infections in japanese healthy male adult subjects.
Latest Information Update: 15 Oct 2018
Price :
$35 *
At a glance
- Drugs Baloxavir-marboxil (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacokinetics
- 04 Oct 2018 Results published in the Clinical Drug Investigation
- 30 Oct 2016 Results assessing safety and pharmacokinetics of S-033188 presented at the IDWeek 2016
- 09 Jun 2016 New trial record